Published in Infection on January 01, 1988
Listeriosis in human pregnancy: a systematic review. J Perinat Med (2011) 2.20
Antibiotic resistance in Listeria spp. Antimicrob Agents Chemother (1999) 1.42
Contribution of penicillin-binding protein homologs to antibiotic resistance, cell morphology, and virulence of Listeria monocytogenes EGDe. Antimicrob Agents Chemother (2006) 1.21
Characterization of recurrent and sporadic Listeria monocytogenes isolates from raw milk and nondairy foods by pulsed-field gel electrophoresis, monocin typing, plasmid profiling, and cadmium and antibiotic resistance determination. Appl Environ Microbiol (2001) 1.08
Antimicrobial activities against 84 Listeria monocytogenes isolates from patients with systemic listeriosis at a comprehensive cancer center (1955-1997). J Clin Microbiol (2003) 0.98
Survival of bactericidal antibiotic treatment by a persister subpopulation of Listeria monocytogenes. Appl Environ Microbiol (2013) 0.87
Sepsis and meningitis due to Listeria monocytogenes. Yonsei Med J (2007) 0.85
Therapeutic activities of antibiotics in listeriosis. Infection (1991) 0.82
Effect of various antibiotics on Listeria monocytogenes multiplying in L 929 cells. Infection (1991) 0.80
A Simple, Reproducible, Inexpensive, Yet Old-Fashioned Method for Determining Phagocytic and Bactericidal Activities of Macrophages. Yonsei Med J (2016) 0.80
Role of PBPD1 in stimulation of Listeria monocytogenes biofilm formation by subminimal inhibitory β-lactam concentrations. Antimicrob Agents Chemother (2014) 0.78
Purification, crystallization and preliminary X-ray crystallographic analysis of Lmo0540 from Listeria monocytogenes. Acta Crystallogr Sect F Struct Biol Cryst Commun (2011) 0.75
Transposon mutagenesis as a tool to study the role of hemolysin in the virulence of Listeria monocytogenes. Infect Immun (1986) 10.02
Tn916-induced mutations in the hemolysin determinant affecting virulence of Listeria monocytogenes. J Bacteriol (1987) 7.18
Introduction of pAM beta 1 into Listeria monocytogenes by conjugation and homology between native L. monocytogenes plasmids. Infect Immun (1984) 3.98
Antibacterial activity of ceftriaxone (Ro 13-9904), a beta-lactamase-stable cephalosporin. Antimicrob Agents Chemother (1981) 3.50
Listeriosis in adults: a changing pattern. Report of eight cases and review of the literature, 1968-1978. Rev Infect Dis (1980) 2.91
Susceptibility of enterococci and Listeria monocytogenes to N-Formimidoyl thienamycin alone and in combination with an aminoglycoside. Antimicrob Agents Chemother (1981) 2.88
Antibiotic synergism against Listeria monocytogenes. Antimicrob Agents Chemother (1972) 2.36
Antibiotic tolerance among clinical isolates of bacteria. Rev Infect Dis (1985) 2.32
Plasmids in Listeria. Plasmid (1982) 1.94
In vitro activity and beta-lactamase stability of a new penem, CGP 31608. Antimicrob Agents Chemother (1987) 1.53
Broad host range of streptococcal macrolide resistance plasmids. Antimicrob Agents Chemother (1984) 1.21
Antimicrobial susceptibilities of Listeria monocytogenes strains isolated from 1958 to 1982 in Sweden. Antimicrob Agents Chemother (1985) 1.13
Delayed bactericidal activity of beta-lactam antibiotics against Listeria monocytogenes: antagonism of chloramphenicol and rifampin. Antimicrob Agents Chemother (1983) 1.04
In vitro activities of trimethoprim and sulfamethoxazole against Listeria monocytogenes. Antimicrob Agents Chemother (1982) 1.01
Failure of cephalosporins to cure experimental listeriosis. J Infect (1984) 0.98
Listeria monocytogens: synergistic effects of ampicillin and gentamicin. Am J Clin Pathol (1979) 0.94
In vitro susceptibility of Listeria monocytogenes to some antibiotics and their combinations. Zentralbl Bakteriol Orig A (1978) 0.84
Effects of erythromycin in combination with penicillin, ampicillin, or gentamicin on the growth of Listeria monocytogenes. Antimicrob Agents Chemother (1982) 0.82
[Antibiotic sensitivity of 139 strains of Listeria serotyped by the National Reference Center in 1983]. Ann Microbiol (Paris) (1985) 0.81
The comparative activities of N-formimidoyl theinamycin (MK0787), moxalactam, cefotaxime and cefoperazone against Yersinia enterocolitica and Listeria monocytogenes. J Antimicrob Chemother (1982) 0.80
[Bacteriostatic and bactericidal effect of penicillins, cephalosporins, aminoglycosides and ampicillin plus gentamicin compared to trimethoprim plus sulfamethoxazole on "Listeria monocytogenes" (author's transl)]. Ann Microbiol (Paris) (1981) 0.80
Murine model for therapy of listeriosis in the compromised host. III. The effect of rifampicin. Chemotherapy (1984) 0.80
In vitro activity of Sch 34343 against enterococci and other gram-positive bacteria. Antimicrob Agents Chemother (1985) 0.79
[Evaluation of the activity of antibiotics against Listeria. Therapeutic perspectives]. Pathol Biol (Paris) (1986) 0.75
Comparative in vitro activities of four macrolides: josamycin, erythromycin, spiramycin and roxithromycin, against 424 anaerobic bacteria. Chemioterapia (1987) 0.78
[Preventive systemic antibiotherapy with ceftriaxone alone in neutropenic patients treated in a protected environment]. Presse Med (1987) 0.76
[Abiotrophia related endocarditis: contribution of molecular biology]. Presse Med (1999) 0.75
[In vitro antibacterial effect of a new oral cephalosporin, cefixime. Results of a multicenter study]. Pathol Biol (Paris) (1989) 0.75
[Septic arthritis caused by Pasteurella multocida. Treatment with a fluoroquinolone]. Presse Med (1989) 0.75
[Empirical treatment of febrile episodes in granulocytopenic patients with a combination of piperacillin and ofloxacin. Preliminary study]. Pathol Biol (Paris) (1990) 0.75
Susceptibility of Listeria strains to imipenem, by species, serotype and origin. J Antimicrob Chemother (1988) 0.75
[Prophylactic systemic antibiotherapy with only ceftriaxone in neutropenic patients treated in a protected environment]. Pathol Biol (Paris) (1988) 0.75
[Evaluation of the activity of antibiotics against Listeria. Therapeutic perspectives]. Pathol Biol (Paris) (1986) 0.75
[Comparative study of first-line ceftriaxone and amikacin in the treatment of severe urinary tract infections in the adult]. Pathol Biol (Paris) (1987) 0.75